| 題庫總數：15 | ||
| 是非題：0 | ||
| 選擇題：15 (A：1、B：1、C：6、D：7) | ||
| 多選題：0 | ||
| roddayeye整理 | ||
| Q | 台灣VRE的 抗藥性比例從2003年至2013年的趨勢為何? | |
| 1.下降 | ||
| 2.持平 | ||
| v | 3.上升 | |
| 4.以上皆非 || | ||
| Q | What is the target of Antimicrobial Stewardship Plan? | |
| 1.To promote ASP through community participation | ||
| 2.To make effort on appropriate use of antibiotics and infection control measures in hospitals and communities to reduce antibiotic resistance and HAI | ||
| v | 3.Both of the above | |
| 4.None of the above || | ||
| Q | How does antibiotic resistance happen? | |
| 1.Antibiotic selective pressure and development of bacterial resistance | ||
| 2.Some bacteria provide their drug-resistant genes to other bacteria | ||
| v | 3.Both of the above | |
| 4.None of the above || | ||
| Q | 針對抗生素的使用，何者正確? | |
| 1.至少給予二種抗生素治療 | ||
| v | 2.視病患情況給予最適當的抗生素治療 | |
| 3.抗生素可長期使用，無需評估 | ||
| 4.抗生素無建置管理機制之必要 || | ||
| Q | 台灣CRE的 抗藥性比例從2003年至2013年的趨勢為何? | |
| v | 1.上升 | |
| 2.下降 | ||
| 3.持平 | ||
| 4.以上皆非 || | ||
| Q | 我國「抗生素管理計畫」實施分成哪些類別單位參與? | |
| 1.專案管理中心(project management center) | ||
| 2.示範中心(demonstration center) | ||
| 3.參與醫院(participating hospitals) | ||
| v | 4.以上皆是 || | |
| Q | 我國「抗生素管理計畫」中專案管理中心的任務為? | |
| 1.推動抗生素管理工作 | ||
| 2.對示範中心及參與醫院進行評/稽核工作 | ||
| 3.提升醫護人員及社區民眾抗生素抗藥性認知 | ||
| v | 4.以上皆是 || | |
| Q | 二戰時期被發現，在人類醫藥史上具有跨時代貢獻的抗生素為何? | |
| 1.Nalidixic acid | ||
| 2.Norfloxacin | ||
| v | 3.Penicillin | |
| 4.Cephalexin || | ||
| Q | What strategy is suggested while the antibiotics are prescribing? | |
| 1.Prospective audit with intervention and feedback | ||
| 2.Formulary restriction and preauthorization | ||
| v | 3.Both of the above | |
| 4.None of the above || | ||
| Q | 下列何者能有效防止抗藥性細菌的傳播? | |
| 1.手部衛生( hand hygiene) | ||
| 2.隔離及防保護(isolation and precaution) | ||
| 3.區域標示(regional labeling) | ||
| v | 4.以上皆是 || | |
| Q | 我國「抗生素管理計畫」預期成果為何? | |
| 1.降低抗生素使用量(reduction of antimicrobial consumption) | ||
| 2.降低抗藥性(reduction of antimicrobial resistance) | ||
| 3.降低醫療照護相關感染(reduction of HAI) | ||
| v | 4.以上皆是 || | |
| Q | 我國「抗生素管理計畫」介入措施包括哪些項目? | |
| 1.抗生素合理使用 (appropriate antibiotic use) | ||
| 2.感染管制措施(infection control) | ||
| v | 3.以上皆是 | |
| 4.以上皆非 || | ||
| Q | 我國「抗生素管理計畫」除醫師外，另與哪些職類人員有關? | |
| 1.感控護理師 | ||
| 2.醫檢師 | ||
| 3.資訊人員 | ||
| v | 4.以上皆是 || | |
| Q | What is the core recommendation of Antimicrobial Stewardship Plan (ASP) mentioned by WHO? | |
| 1.Surveillance of antimicrobial resistance and rational antibiotics use | ||
| 2.Stopping the selling of antibiotics without prescription | ||
| 3.Infection control (IC) measures | ||
| v | 4.All of the above || | |
| Q | What is the major challenge of patient safety mentioned by WHO? | |
| 1.Healthcare-associated infections | ||
| 2.Safe surgery | ||
| 3.Antibiotic resistance | ||
| v | 4.All of the above || | |
請先 登入 以發表留言。